[18F]NOTA-ABY030
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]NOTA-ABY030, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma [Phase 1]